FGF2 and neoplasm: Specifically, LMWHs interact with growth factors such as VEGF (vascular endothelial growth factor) and bFGF (basic fibroblast growth factor), interfering with their activity and inhibiting angiogenesis, thus slowing tumor progression [243].